Category: News and Announcements
All four Singapore patients’ AngelMed Guardian alarms are programmed and turned onScientific Webinar of the AngelMed Guardian presented to cardiac specialists
Hydrix Limited (ASX: HYD, ‘Hydrix’ or the ‘Company’) is pleased to provide the following update regarding the four patient implants of the AngelMed Guardian in Singapore announced on 17 August 2020.
AngelMed Guardian device Alarms are now programmed and turned on
All four patients post-operative implant procedures have been completed. Each patient implanted device (IMD) gathered ECG data over the past two-weeks to establish the patient’s baseline heart signal. Hydrix Medical and Angel Medical Systems field clinical engineers configured each IMD alarm to each patient’s individual physiology. The IMD is fully functioning and thresholds set to recognise changes to the patient’s physiology indicative of a heart attack. With this simple post-operative procedure complete, these patients are now benefitting from the device.
In commenting on the latest milestone, Paul Kelly, General Manager – Hydrix Medical said:
“We are very pleased by the success of the four implants in Singapore by Dr Lam which lays the foundation for future growth. An estimated 500,000 people annually suffer from an acute coronary syndrome event of which many may benefit from the AngelMed Guardian.”
Hydrix Medical and Angel … Read More »
First AngelMed Guardian patient implants in Asia Pacific for Hydrix MedicalThe four implants were carried out under the guidance of leading Cardiologist Dr Leslie LamThis significant milestone provides a foundation for future implants under early access schemes in Singapore and Australia
Hydrix Limited (‘Hydrix’ or ‘the Company’) (ASX: HYD) is pleased to announce its first supply and implant of the AngelMed Guardian device.
Four implants were performed over a 3-day period last week in Singapore and recipients have since been discharged from hospital. Each implant procedure was supported by a Hydrix Medical field clinical engineer in Singapore with real-time remote support from Angel Medical Systems staff in the USA.
The successful implants follow Hydrix’s announcement on 13 March 2020 that it had acquired an exclusive seven-year distribution agreement for eight Asia Pacific countries to distribute the AngelMed Guardian device, the world’s first FDA approved implantable heart attack warning system.
Gavin Coote, Hydrix Executive Chairman said:
“The AngelMed Guardian implants are a significant milestone for Hydrix and AngelMed. This achievement demonstrates strong execution of our buy, build, invest strategy to create product revenue and earnings streams, and of equal importance, reflects progress in our aspiration to meaningfully improve a billion lives.”
Speaking from New Jersey, Dr … Read More »
XTEK Limited (ASX: XTE) (XTEK, or the Company) is pleased to announce a successful placement to existing shareholders and new investors to raise approximately A$9.2m (“Placement”), which will be followed by a share purchase plan (“SPP”) to raise up to A$2m.
– XTEK announces record FY20 revenue and updated FY20 earnings guidance (unaudited)
– XTEK has successfully raised ~A$9.2m via an oversubscribed placement at A$0.69 per share, supported by existing and new investors, with several institutions welcomed to the register
– SPP to raise up to A$2.0m will follow the placement, with eligible shareholders offered the opportunity to acquire additional new shares on the same terms as the placement
– Funds will be used to execute XTEK’s international ballistics strategy including increasing US XTclaveTM manufacturing capacity and accelerate growth in other key operations
XTEK Managing Director, Philippe Odouard, said:
“We are pleased to welcome new institutional investors to our share register. Their support for this transaction reflects the endorsement of our financial performance, business strategy, progress made in commercialising XTclaveTM products and exciting outlook. We look forward to accelerating our ballistics commercialisation strategy by increasing our manufacturing capacity in the US, effectively doubling XTclaveTM revenue capacity.
“We are excited to continue commercialising our … Read More »
4QFY20 & FY20 Highlights1:
FY20 operating revenue (preliminary and unaudited) of $15.0m, up 12.6% on FY19, despite impacted COVID-19 4QFY20 revenue of $3.0m;4Q20 cash operating profit2 of $0.02m, driven by swift implementation of cost reduction initiatives;FY20 cash operating loss2 of $0.26m, a significant improvement of $1.69m year on year;Capital raise of $3.0m from a fully underwritten entitlement offer and placement;Pro forma 30 June cash on hand of $4.2m after $0.75m debt reduction;$50m Services pipeline is a solid book of business to generate conversions from; andFirst sales (implants) of Angel Medical Inc. (AngelMed) Guardian devices in Singapore are scheduled in the September quarter (1Q’21).
Hydrix Limited (‘Hydrix’ or ‘the Company’) (ASX: HYD) today released its Appendix 4C for the three months ended 30 June 2020 (4Q20) and a business update for 4Q20.
Hydrix Executive Chairman, Gavin Coote, said:
“The fourth quarter and full year results represent a solid performance despite the challenging COVID-19 environment. It was particularly pleasing that the core business achieved a cash operating profit in the fourth quarter. We made significant progress with Hydrix Medical acquiring the exclusive rights to distribute the AngelMed Guardian System in APAC. Further, we are pleased to announce the first sales and implants of the Guardian System … Read More »
Australian Healthcare Software provider Global Health Limited (ASX: GLH) (“Global Health” or “Company”) is pleased to announce an extension of the Company’s Lifecard partnership with Diabetes Victoria for a further 12 months to June 2021.
One in four Australian adults over the age of 25 years either has diabetes or have impaired glucose metabolism. Currently, there is no cure in sight.
In order to reduce the risk of developing additional complications, Victorians living with diabetes can use the Company’s Lifecard Personal Health Record to help them monitor key indicators and maintain a healthy lifestyle.
The initial partnership was launched at the Diabetes Expo in July 2019 where Lifecard was showcased to conference attendees.
Through the next 12 months, Lifecard registrations have grown organically with direct registrations increasing from approx. 1,000 to more than 25,000.
Lifecard is integrated with the Company’s ReferralNet Secure Messaging platform enabling subscribers to receive their health and medical information directly into their Personal Health Record in machine and human readable formats from their healthcare providers, through industry-standard Secure Messaging platforms such as ReferralNet and Telstra Health’s Argus Connect.
Subscribers of Lifecard have total control of their records and can choose to share some or all of their personal health information with nominated healthcare providers, carers, coaches and family members.
Given the migrant community … Read More »
Media Release: Compumedics Preliminary 30 June 2020 Business Update Delivers Solid Performance Despite COVID-19 Pandemic
Core Business (preliminary unaudited data)
Positive EBITDA for FY20 should result from immediate expense mitigation measures taken and various Government assistance obtained Cash ahead of expectations at 30 June 2020 at $6.5m ($3.3m at 31 December 2019)Additional bank borrowing facilities in Australia and Germany were secured, with unused bank borrowing facilities of $3.5m at 30 June 2020 H2 revenues at about $17m not significantly lower than H1 revenues of $18.3m despite most of the Company’s key markets being affected by COVID-19 pandemic during Q4. As a result, revenues for FY20 are approximately $35.3m, down 15% compared to FY19 of $41.5mChina based revenues down 43% over the prior year, US down 11%. Australia and DWL finished in line with the prior year. Japan grew 192% over the prior year, as our neurological distribution partner, Fukuda Denshi, continued to expand in this key market. No further MEG revenue was booked in FY20Initial sales pipelines for FY21 consistent with same time last year, with good new sales orders in the first weeks of FY21. Sales forecasts will remain problematic due to COVID-19 pandemicCompumedics continues to monitor the development of the COVID-19 pandemic and will adjust the business to safeguard its employees, whilst continuing to navigate … Read More »
XTEK Limited (ASX: XTE) (XTEK, or the Company) is pleased to announce that it has received a purchase order from the Australian Defence Force (ADF) for the supply of additional AeroVironment WASP AE Small Unmanned Aerial Systems (SUAS). The order is worth ~A$2.8m and is in addition to the ongoing SUAS supply contract to the ADF. This order represents XTEK’s strong and continued relationship with the ADF.
– Purchase order worth ~A$2.8m received from the ADF for WASP AE SUAS – delivery in FY2021
– Ongoing supply of spare parts and engineering services to support the ADF SUAS fleet, FY20 revenue worth A$8m
XTEK Managing Director, Philippe Odouard, said
“The supply and maintenance of SUAS remains an ongoing focus for XTEK. Our SUAS business underpins our increasing revenue, with recurring attributes. In addition, our facility in Canberra is in full operation providing critical repair and maintenance services to support the ADF’s growing SUAS fleet. We are the full-service SUAS supplier of choice for the ADF and look forward to continue servicing our Defence Force.”
XTEK has a strong relationship with the ADF, with more than fifty AeroVironment WASP AE SUAS delivered to date, and more SUAS scheduled for delivery in the near term. … Read More »
Australian Healthcare Software provider Global Health Limited (ASX: GLH) (“Global Health” or “Company”) has made a significant inroad into the Victorian Community Health Sector with the signing of Peninsula Health on a 3-year contract, with the first year of services and licensing revenue totalling $725,000.
Implementation of MasterCare EMR (Electronic Medical Record), MasterCare+, ReferralNet Secure Message Delivery and Dashboards-as-a-ServiceCombined $725,000 in revenue from initial year of the contractOver 800 new users on the MasterCare platformIntegration with DXC Technology’s i.PMIntegration with Cerner Corporation’s Clinical Applications
Global Health’s rapid adoption through the Victorian Community Health setting has further extended its reach by landing Peninsula Health, one of Victoria’s largest Community Healthcare providers, on a 3-year contract. Not only will this contract increase users on Global Health’s MasterCare platform, but it will also have MasterCare integrate with DXC Technology’s i.PM Patient Administration System and Cerner Corporation’s Clinical Applications.
Global Health’s MasterCare platform will enable Peninsula Health to meet the key reporting requirements for the NDIS (National Disability Insurance Scheme), HACC (Home & Community Care), CHSP (Community Home Support Program), VADC (Victorian Drug & Alcohol Collection) and VINAH (Victorian Integrated Non-Admitted Health) programs, as well as provide support for their Allied, Community and Mental Health users.
Breaking … Read More »
XTEK Limited (ASX: XTE) (XTEK, or the Company) is pleased to announce that the Company expects to deliver FY20 revenue in excess of A$42m (unaudited). XTEK also provides an update on its ballistics operations including the recent progress of the optimised XTEK manufacturing capability (including XTclave™) resulting in an increase to production capacity and potential revenue generation.
XTEK expects to achieve FY20 revenue in excess of A$42m (FY19: $37.9m)XTEK manufacturing capability (including XTclave™) optimised with the ability to produce up to ~A$40m p.a. of revenue, doubling previous forecastXTEK is well placed to service growing interest in its ballistic solutions with further orders expected in the near-to-medium term, underpinning XTEK’s future revenue expectations
XTEK Managing Director, Philippe Odouard, said:
“We are delighted with our strong financial performance in FY20, especially given the increased volatility and uncertainty in the recent trading period. In addition, we have also progressed the optimisation of the XTclave™ manufacturing capability, which has efficiently unlocked significant value by increasing our production capacity and revenue generation potential.”
“We have the key pillars in place internally to build towards a A$100m business in the medium term, with a growing pipeline supported by our active and advanced discussions with potential customers, distributors and suppliers. … Read More »
Media Release: Hydrix Announces Fully Underwritten Entitlement Offer And Placement To Raise $3 Million
Capital raising of $3 million, comprising a $1 million Placement and a $2 million Entitlement OfferEntitlement Offer fully underwritten by Henslow Pty LtdFunds raised to pay down debt, increase financial strength and flexibility to navigate COVID-19 disruptions, grow Hydrix Services business and expedite the first sales and implants of AngelMed Guardian® System.
Hydrix Limited (ASX: HYD) (“Hydrix” or “Company”) announces a capital raising of $3.0 million by way of a 1 for 3 pro-rata entitlement offer to raise $2.0 million (Entitlement Offer) and a placement to raise $1.0 million (Placement), at an issue price of 7.5 cents per share, with subscribers to receive one new 12 cents, 2 year option, for every 3 new shares subscribed.
Henslow Pty Ltd is Lead Manager to the Placement and Underwriter to the Entitlement Offer.
Use of funds
Hydrix is undertaking the Entitlement Offer and Placement to raise $3 million. Funds raised will be used to:
Pay down $0.75 million of the $4.0 million loan provided by Pure Asset Management Pty Ltd (Lender) under a facility agreement dated 15 November 2019 (Facility Agreement). Hydrix and the Lender have entered into a variation to the Facility Agreement, under which the Company will prepay part of the outstanding loan without … Read More »